drugset
drugset / Trial / NCT00597233

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

NCT00597233 ↗

Phase 4 Completed 91 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in South America. This aim of this trial is to evaluate the comparative prandial blood glucose lowering profile in subjects with type 1 diabetes.

Timeline

Start
2002-10
Primary completion
2002-12
Completion
2002-12

Publications

  • Results Cintora H, Rodrigues M, Klyver MI, Claus-Hermerg H, González G, Kanevsky D, Medrano G, Sánchez A. Insulina Aspártica versus insulina soluble humana: Estudio comparativo cruzado en pacientes con diabetes tipo 1. Revista de la Sociedad Argentina de Diabetes 2004; 38 (4): 218-224

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic — —
Subject insulin aspart Protein / enzyme biologic — —
Subject soluble human insulin Unknown — —

Indications

type 1 diabetes mellitus